Home
Home

Flu

Will Influenza A H7N9 Generate Opportunities For Pharma?

Will Influenza A H7N9 Generate Opportunities For Pharma?
Seeking Alpha

3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak

3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Seeking Alpha

BioCryst's shares spike on hope that flu drug can rise from the grave

BioCryst's shares spike on hope that flu drug can rise from the grave
Fierce Biotech

In U.S., flu vaccine worked in just over half of those who got it

In U.S., flu vaccine worked in just over half of those who got it
Reuters

Will The Flu Vaccine Race Send Novartis Higher?

Will The Flu Vaccine Race Send Novartis Higher?
Seeking Alpha

Flu Crisis Prompts Broadest Vaccine Redesign Since 1981

Flu Crisis Prompts Broadest Vaccine Redesign Since 1981
Bloomberg

Drugmakers report U.S. shortages of flu vaccine, Tamiflu

Drugmakers report U.S. shortages of flu vaccine, Tamiflu
Reuters

Investing in a better flu shot

Investing in a better flu shot
Markewatch

FDA approves Novartis cell culture flu vaccine

FDA approves Novartis cell culture flu vaccine
Pharma Times, UK

'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production

'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production
Seeking Alpha